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Abstract
Purpose Integration of a 3D reconstruction of the left atrium
into cardiac mapping systems can aid catheter ablation of
atrial fibrillation (AF). The two most widely used systems
are NavX Fusion and Cartomerge. We aimed to compare the
clinical efficacy of these systems in a randomised trial.
Methods Patients undergoing their first ablation were
randomised to mapping using either NavX fusion or
CartoMerge. Pulmonary vein isolation by wide area
circumferential ablation was performed for paroxysmal
AF with additional linear and fractionated potential ablation
for persistent AF. Seven-day Holter monitoring was used
for confirmation of sinus rhythm maintenance at 6 months.
Results Ninety-seven patients were randomised and under-
went a procedure. There was no difference in the primary
endpoint of freedom from arrhythmia at 6 months (51% in
the Cartomerge group vs. 48% in the NavX Fusion group,
p=0.76). 3D image registration was faster with Cartomerge
(24 vs. 33 min, p=0.0001), used less fluoroscopic screening
(11 vs. 15 min, p=0.039) with a lower fluoroscopic dose
(840 vs. 1,415 mGyCm
2, p=0.043). There was a strong
trend to lower ablation times in the Cartomerge group,
overall RF time (3,292 s vs. 4,041, p=0.07). Distance from
3D lesion to 3D image shell was smaller in the Cartomerge
group (2.7±1.9 vs. 3.3±3.7 mm, p<0.001).
Conclusions Cartomerge appears to be faster and uses less
fluoroscopy to achieve registration than NavX Fusion, but
overall procedural times and clinical outcomes are similar.
Keywords Atrial fibrillation.Image integration.3D
mapping.Catheter ablation
1 Introduction
Catheter ablation procedures for atrial fibrillation (AF) are
performed with increasing frequency since the technique
was first described over 15 years ago [1]. Technological
developments appear to have reduced X-ray doses and may
help newer centres establish an AF ablation programme [2].
3D mapping systems are widely used in catheter ablation
of AF. Integration of a previously acquired image of the left
atrium (LA) into the electroanatomical map offers several
potential advantages, including visualization of the com-
plex anatomy of the left atrium, reduction of fluoroscopy
time and improved results [3–8]. The two most widely used
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CA, USA) and NavX Fusion (St. Jude Medical Inc., Saint
Paul, MN, USA). Although both systems have been indepen-
dentlyvalidated[9–12], their clinical utility has not previously
been directly compared in a randomised trial.
2 Methods
2.1 Study population
All eligible patients with either paroxysmal or persistent AF
undergoing their first catheter ablation at St Bartholomew’s
Hospital were invited to participate in this study. All
patients had symptomatic documented AF and had failed
1 or more class I and/or class III antiarrhythmic drugs.
Exclusion criteria were <18 years of age, left ventricular
ejection fraction <40%, known congenital heart disease or
involvement in another study. The study was approved by
the Outer North East London Research and Ethics
committee (study number 07/4Q0603/66), and patients
gave written informed consent. The design of the study
followed the Consort guidelines for randomised trials [13].
2.2 LA image acquisition
A multislice helical contrast CT was performed using GE
Light-speed Ultra 8-slice scanner (GE Healthcare Technol-
ogies, Waukesha, WI, USA). The technique used for CT
acquisition has been previously described [4]. Towards the
end of the recruitment period, it became possible to use a
cardiovascular magnetic resonance (CMR) scan image for
segmentation of the LA, using a Seimens Magnotron 1.5-T
MRI with cardiac gating.
2.3 Operator experience
Our centre had experience of >100 cases using image
integration for each system at the start of patient recruitment.
Image integration was performed by operators (ME, MD, SS,
RS) assisted by technicians, each of whom had performed >20
image integrations and undergone training prior to the trial.
2.4 Procedure
The procedure was performed in the post-absorptive state
under conscious sedation. In patients with a CHADS2 score
of >1, oral anticoagulation was administered for at least
4 weeks prior to the procedure. Transesophageal echocar-
diography was performed within 24 h prior to the procedure
to exclude LA thrombus.
Local anaesthesia and conscious sedation was used for
all procedures. Venous access, number and size of sheaths
were at the operator’s discretion. In the majority of cases, three
venous sheaths (1×7 F short sheath, 2×8 F long sheath) were
inserted via the right femoral vein without ultrasound guidance.
If the patient was in AF at the start of the case, a decapolar
catheter was positioned in the coronary sinus; otherwise, a
quadripolar catheter was used. Two transseptal punctures were
performedunder fluoroscopicguidancewithanEndry’scoaxial
needle using continuous pressure monitoring. Two long
Mullin’s sheaths were advanced into the LA, and a pulmonary
vein mapping catheter (Ortbiter
TM Woven, Bard Electrophy-
siology, Lowell, MA, USA) and an irrigated tip ablation
catheter (either Navistar
TM (Cartomerge group) or Celsius
TM
(NavX Fusion group) Thermocool, Biosense Webster Inc.,
Diamond Bar, CA, USA) were advanced through the sheaths.
2.5 Image integration
2.5.1 NavX fusion
The CT left atrium (CTLA) was imported into the proprietary
Verisimo
TM CT segmentation software. Image segmentation
was performed as previously described [10], ensuring that
pulmonary veins were visible to second-order branch points
and the left atrial appendage (LAA) was included in the scan.
The rendered 3D image was imported into the NavX study. A
geometry of the LA was collected from the PV mapping
catheter, with particular attention given to collecting points at
the PV ostia. Further geometry was collected from the
mapping catheter. Field scaling was applied which refers to
a computer algorithm that uses the known fixed separation of
poles on the mapping catheter and the PV catheter to calibrate
the non-linear electrical field data to real 3D space. Field
scaling effectively reduces the apparent flattening and
stretching of the LA geometry, making it easier to perform
image integration [11]. To integrate the image, 15 to 30
fiducial points that correspond to landmarks clearly visible on
both CTLA and geometry are chosen. These often include,
but are not limited to, venous bifurcations, the LAA, the
intra-atrial septum, the mitral ring as well as several points on
the roof, posterior wall and floor of the LA. When fiducial
selection is complete, fusion is attempted. The geometry is
rescaled to fit the segmented image, using the fiducials to
effectively allow ‘stretching’ of the geometry to match the
exported scan image. Thereafter, catheters can be located on
the scanned CT image shell, the matched geometry or both.
2.5.2 Cartomerge
Previously acquired scan images were imported into the
proprietary Cartomerge image processing tool software.
Segmentation was performed, ensuring that veins were
visible to second-order branch points, and the segmented
image imported into the Cartomerge study. The ablation
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retrograde pulmonary venography performed to confirm its
exact position in relation to venous branch points. The
position of the ablation catheter was identified and a Carto
landmark point taken. This point was linked to its
corresponding location on the segmented CT/CMR shell.
Once points in all four veins had been acquired, landmark
registration was applied. According to operator preference,
further surface registration could be applied. Image inte-
gration was considered successful if the operator considered
it to give an accurate representation of catheter location
within the atrial chamber.
2.6 Ablation
PV WACA was performed using an irrigated tip catheter
with power limited to 30 W and temperature to 50°C, with
the endpoint electrical isolation determined by a circular PV
catheter. In patients in whom AF persisted, further ablation
was performed using a combination of (a) roof line, (b)
mitral isthmus line, (c) coronary sinus endocardial and
epicardial (within the CS) lines and (d) complex fraction-
ated electrograms. If at any stage AF organized into atrial
tachycardia (AT), activation and entrainment mapping was
performed. If AF persisted following the linear ablation and
targeting of fractionated electrograms, DC cardioversion
was performed. Cavotricuspid isthmus ablation was per-
formed only if patients had previously documented typical
atrial flutter or organized into this during other ablation.
2.7 Follow-up
All patients were reviewed in clinic at 3, 6 and 12 months
following the procedure. If no episodes of AF recurrence
had been documented, a 7-day Holter monitor was
performed at 6 and 12 months.
2.8 Endpoints
The primary endpoint was freedom from AF at 6 months,
with AF recurrence defined either by documentation of
symptomatic arrhythmia or arrhythmia on a 7-day Holter
monitor at 6-month follow-up. Secondary endpoints were
procedural, screening and energy delivery times for all
stages of the procedure and complications and freedom
from AF at 1 year following a single procedure
A sub-study aimed to determine navigational accuracy of
image registration in clinical use. Data were taken from a
consecutive series of 21 patients in each group where image
registration had been used throughout the case. The
distance from LA lesions points to their corresponding
nearest location on the integrated image shell was assessed.
Techniques for this assessment in both technologies have
been previously described [10, 14]. This assessment
assumes that lesion points are placed on the endocardial
surface of the LA; lesions placed outside the endocardial
LA (e.g. within coronary sinus) were excluded in this
analysis. In Cartomerge, the three-dimensional linear
distance from each lesion to the nearest point on the
integrated image shell is calculated within the Cartomerge
software. An equivalent distance can be calculated from
data exported from NavX fusion. Lesion coordinates are
exported separately, initially as 3D lesions and subsequent-
ly as projected onto the nearest corresponding point of the
integrated image (‘Project on Dif’). The primary objective
of this sub-study was to compare observed accuracy during
clinical use; therefore, both field scaling and surface
registration were permitted. Offline analysis was performed
using custom software to calculate linear distances between
projected and 3D points for each lesion (Matlab, The
Mathworks Inc., Natick, MA, USA).
2.9 Statistical analysis
Assuming an overall single procedure success rate at
6 months of 60%, 63 patients were required in each group
to achieve an 80% chance of detecting a 10% difference
(alpha=0.05, two-tailed) in outcomes between groups.
Univariate continuous variables were compared with
Student’s T test or the Mann–Whitney U test as appropriate.
Proportions were compared using the chi-squared test.
Univariate survival analyses were performed by the
Kaplan–Meier method, and multivariate survival regression
analyses were performed using the Cox regression method.
Statistical analyses were carried out using PASW 18.0
(SPSS Inc., Chicago, IL, USA) software and Graphpad
Prism 4 (Graphpad Inc., San Diego, CA, USA). Analyses
performed included data from all patients who underwent
an ablation procedure. Data are presented on an intention-
to-treat basis; hence, presented procedural data include
information from patients who had unsuccessful image
integration. A 6-week blanking period was observed, but
timing of recurrence was ascribed to the earliest docu-
mented recurrence (even within this 6-week period). Values
are given as means±standard deviation unless otherwise
stated.
3 Results
3.1 Randomisation and baseline factors
One hundred one patients were enrolled. The trial design
and randomisation [13] is summarised in the Electronic
Supplementary Material, Figure 1. A total of 97 patients
underwent catheter ablation, and 98% of these received
J Interv Card Electrophysiol (2012) 33:161–169 163their assigned treatment. Two patients who were allocated
NavX Fusion in randomisation underwent ablation with a
non-trial mapping system due to computer malfunction of
the patient interface unit. Four patients (three randomised to
Cartomerge, one to NavX Fusion) did not complete a
catheter ablation study following randomisation, all citing
recent improvements in symptoms.
Baseline clinical factors did not differ between the two
groups (Table 1). Twenty-five patients in the NavX Fusion
group and 23 patients in the Cartomerge group were in
persistent or longstanding persistent AF, with a median time
since first episode of AF 59 months (range 2–240) vs.
63 months (8–306) (p=0.66). An interim analysis of the
primary endpoint following recruitment of 90 patients
determined that statistical significance in the primary
endpoint was unlikely to be reached, and recruitment was
terminated at 101 patients.
3.2 Primary endpoint
Catheter ablation was performed in 97 of 101 patients. The
primary endpoint of freedom from AF off antiarrhythmic
drugs at 6 months was reached by 24 patients in both
groups (Cartomerge 51%, NavX fusion 48%, χ
2, p=0.76).
There was no difference in the time to recurrence of
arrhythmia as measured by the log-rank statistic (p=0.74)
(Fig. 1).
Procedural outcomes are summarised in Table 2.A t
the end of the ablation procedure, 45 (96%) patients
completing in the Cartomerge group and 50 patients
(100%) in the NavX fusion group were in sinus rhythm
(p=0.58). Two patients from the Cartomerge group
remained in an arrhythmia at the end of the procedure
despite attempts at DC cardioversion, one in AF, the other
in a left-sided AT. In patients with persistent AF, DC
cardioversion was used to achieve sinus rhythm in 17
(74%) patients in the Cartomerge group and 15 (60%)
patients in the NavX fusion group (χ
2, p=0.12). After
6 months clinical follow-up, 66% patients in the Carto-
merge group and 68% in the NavX fusion group were in
sinus rhythm following a single procedure (p=0.91) as
documented with a 12 lead ECG in clinic. At 1 year, 44%
of patients in the Cartomerge group vs. 38% patients in
NavX Fusion group remained free from any documented
arrhythmia on 7-day Holter and off antiarrhythmic drugs
following a single procedure (p=0.6).
3.3 Procedural factors
Procedural time points are summarised in Table 3 and
Fig. 2. Time taken for overall ablation procedures was
similar between Cartomerge and NavX fusion, but
procedures for persistent atrial fibrillation (persAF) were
significantly longer than those for paroxysmal atrial
Table 1 Demographic and
baseline factors Randomisation
Cartomerge NavX Fusion p
Number consented 50 51
Underwent ablation 47 50 >0.9
Diagnosis PersAF (n) 49% (23) 50% (25) >0.9
Male 67% 29% 0.66
Age at procedure 59 (25–79) 63 (34–71) 0.53
Hypertension? 41% 44% 0.81
Structural heart disease? Normal 80% 84% 0.73
IHD 13% 8%
Cardiomyopathy 7% 8%
Rhythm at procedure start AF 50% 46% 0.72
AT 0% 0%
Typical flutter 4% 2%
SR 46% 52%




52 % 0 %
AF duration (months) 60 (2–240) 64 (8–306) >0.9
164 J Interv Card Electrophysiol (2012) 33:161–169fibrillation (median [range]) (199 [74–360] vs. 294 [90–
520]min, p<0.0001). Registration was faster with Carto-
merge (24 vs. 33 min, p=0.0001), used less fluoroscopic
s c r e e n i n g( 1 1v s .1 5m i n ,p=0.039) and had a lower
fluoroscopic dose (840 vs. 1,415 mGyCm
2, p=0.043) than
with NavX Fusion. There was a trend to lower ablation
times in the Cartomerge group (overall RF time 3,292 s
vs. 4,041, p=0.07). All pulmonary veins were confirmed
to be isolated at the end of the case in 44 patients (94%) in
the Cartomerge group vs. 47 patients (94%) (p>0.9). The
time taken for initial isolation of each pair of PVs was
similar between groups. Twenty-four patients (51%) in the
Cartomerge group vs. 23 patients (46%) had pulmonary
electrical reconnection apparent during the case requiring
further ablation. Times from procedure start (local anaes-
thetic to skin) to completion of isolation of both sets of
veins were not significantly different between groups (164
vs. 177 min, p=0.22).
3.4 Image integration
3D image integration (merge or fusion) was completed and
used more often with Cartomerge than NavX fusion (44
patients (94%) vs. 39 patients (78%); p=0.046). The poor
quality of CT images following segmentation was given as
the reason for failure of image integration in all three
patients in the Cartomerge group. Reasons for failure of
NavX Fusion image integration were listed as failure to
achieve adequate fusion (five patients), inability to import
CT images (file format mismatch) (one patient), instability
of the reference electrode (two patients) and poor quality
CT images (three patients). CT integration was abandoned
during the case following achieving adequate registration in
a further three patients in each group. In all cases, this was
because of apparent evolving mismatch of anatomy with
registration. 3D registration was successful for the entire
case for 87% of patients in the Cartomerge group and 72%
of patients in the NavX fusion group (p=0.12).
3.5 Navigational accuracy of image integration
Three thousand one hundred seventy-four LA lesions from
Cartomerge and 2,712 lesions from NavX fusion were
analysed (from 21 patients in each group with subjectively
satisfactory image integration). Cartomerge lesions were
significantly closer to the 3D shell than those of NavX
fusion (2.0±0.5 vs. 3.4±0.9 mm, p<0.0001). The maxi-
mum distance from lesion to shell per patient was lower in
Cartomerge than with NavX fusion (10.2±0.7 vs. 15.9±
1.1 mm, p=0.0002; Table 4).
Fig. 1 Clinical outcomes—Kaplain–Meier diagram of survival free
from documented episodes of AF
Table 2 Procedural outcomes
Cartomerge NavX Fusion p
Procedures attempted (PersAF) 47 (23) 50 (25) 0.30
Method of restoration of sinus
rhythm in persAF
Ablation 17% 36% 0.12
DC cardioversion 57% 56%
Internal cardioversion 17% 4%
Failure of cardioversion 9% 0%
Rhythm at discharge Atrial fibrillation 2% 0% 0.34
Atrial tachycardia 2% 0%
Sinus rhythm 96% 100%
ECG rhythm 3 month Atrial fibrillation 15% 23% 0.67
Atrial tachycardia 10% 9%
Sinus rhythm 74% 67%
ECG rhythm 6 months Atrial fibrillation 21% 22% 0.91
Atrial tachycardia 13% 10%
Sinus rhythm 66% 68%
Freedom from AF at 6 months without drugs (n)? 51% (24) 48% (24) 0.76
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The cost per case of the comparative navigation systems
was calculated using methods as previously described [8],
where using a quadripolar catheter as a reference cost unit
of 1 (Table 5). There was no difference between the actual
equipment costs of using either system (30.1±0.2 vs. 29.9±
0.2, p=0.5). This figure does not take account of the ability
to re-use Carto location patches between consecutive
patients within a 24-h period, which can substantially
reduce costs if more than one patient is undergoing CA of
AF in the same catheter laboratory on that day.
3.7 Adverse events
A total of 11 adverse events were reported during the study
(11%). There were three cases of cardiac tamponade, one
(2%) in the Cartomerge group and two (4%) in NavX
fusion group. All were successfully treated with pericardio-
centesis. Six patients, four (9%) in the Cartomerge group
and two (4%) in the NavX fusion group, developed
haematomas requiring hospital admission to be extended.
Two patients (4%) in the Cartomerge group developed
minor focal neurological symptoms following the proce-
dure, a cerebrovascular event was confirmed on MRI in one
Table 3 Procedural time points,
fluoroscopic doses and RF
times
Total times include times for
rechecking of pulmonary veins
and linear lesions, mapping for
ATs and ablation for linear
lesions and CFAEs in persAF
Cartomerge NavX fusion p
Mean (±SD) Mean (±SD)
Start until completion of
transseptal punctures
Time (min) 35 (±19) 31 (±16) 0.24
Screening (min) 8 (±6) 6 (±5) 0.18
Fluoroscopic dose (mGycm
2) 821 (±1,154) 647 (±890) 0.42
Registration Time (min) 24 (±15) 33 (±14) 0.002
Screening (min) 11 (±7) 15 (±7) 0.03
Fluoroscopic dose (mGycm
2) 840 (±725) 1,415 (±1,670) 0.03
Isolation of RPV Time (min) 54 (±27) 58 (±30) 0.57
Screening (min) 16 (±11) 22 (±20) 0.08
Fluoroscopic dose (mGycm
2) 853 (±870) 1,632 (±2,061) 0.02
RF time (s) 1,314 (±674) 1,466 (±764) 0.34
Isolation of LPV Time (min) 51 (±23) 56 (±29) 0.37
Screening (min) 11 (±8) 12 (±13) 0.62
Fluoroscopic dose (mGycm
2) 897 (±1,366) 1,085 (±1,384) 0.51
RF time (s) 1,105 (±578) 1,268 (±783) 0.28
Total Time (min) 242 (±94) 263 (±89) 0.26
Screening (min) 57 (±25) 58 (±26) 0.79
Fluoroscopic dose (mGycm
2) 4,520 (±4,412) 5,295 (±4,935) 0.42
RF time (s) 3,292 (±2,001) 4,041 (±1,994) 0.07
Total common procedure
time (min)
164 (±55) 177 (±49) 0.22
Fig. 2 Key procedural time
points, shown as cumulatives
(rather than true order in which
ablations progressed). This
illustrates the contributions of
each procedural stage to the
overall time taken. Inset numer-
als show times for each stage as
mean±SD. Time from start of
case to registration was signifi-
cantly shorter with Cartomerge,
but this did not translate into
overall reduced case time. pAF
paroxysmal atrial fibrillation,
persAF persistent atrial fibrilla-
tion, DTSP double transseptal
puncture, RPV right pulmonary
vein, LPV left pulmonary vein
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patients made a full functional recovery within 48 h. No
symptomatic pulmonary venous stenosis was reported in
either group, and no asymptomatic pulmonary venous
stenosis was observed in any case undergoing a redo
procedure or on further imaging performed for clinical
indications.
4 Discussion
The principal findings of this study are that Cartomerge
allowed a slightly faster and more accurate registration of
the reconstructed LA than NavX fusion, but overall
procedural times and clinical outcomes were unaffected
by mapping system used. A reduction in X-ray screening
associated with registration using Cartomerge was ob-
served, but this was small in comparison to overall
screening and did not translate to an overall reduction in
X-ray use. Less ablation time was used with Cartomerge
than with NavX fusion, and similar procedural results
were achieved.
Clinical results, measured as freedom from AF at
6 months, were not different between groups. Although
one system cannot be claimed to be superior overall to
another for the catheter ablation of atrial fibrillation, the
slightly faster procedural stages seen with Cartomerge and
greater accuracy, particularly in image registration, may
encourage its use for pulmonary vein isolation procedures.
This is the first prospective, randomised clinical trial
comparing the two most widely commercially available 3D
mapping systems. Image integration of a previously
acquired anatomical dataset to 3D mapping systems offers
several advantages in the ablation of complex arrhythmias,
particularly AF where a good knowledge of anatomy is key
to procedural success. The technique of image integration,
particularly the process of registration, with Cartomerge
and NavX fusion is quite distinct.
The Carto XP system locates catheter position in 3D
space by trigonometry from three separate magnetic (linear)
fields. The relative field strength in three planes enables
location of a proprietary mapping catheter. User-selected
locations (‘points’) can link 3D locations with anatomical
boundaries, and known anatomical landmarks can be used
for rapid registration of a previously LA image. The
technique used in this trial has previously been described
[4]. As magnetic fields vary in a linear manner (actually
log-linear) with distance, and a fixed movement of the
ablation catheter tip produces a corresponding and predict-
able change in magnetic fields detected by the catheter tip.
Anatomical data can thus be imported into the Carto system
without need for further calibration.
In contrast, NavX uses three orthogonal high-frequency
electric fields to locate catheter position. Impedance
changes due to catheters movement can be tracked in three
dimensions and relative positions of catheters derived.
Unlike magnetic fields, electrical fields within the human
body are non-linear; thus, a fixed deviation of catheter
produces an impedance change dependent on the exact
location of the catheter within the body. The non-linearity
of the NavX maps often gives an apparent anteroposterior
flattening of the LA, and the anatomic dataset cannot be
simply matched to position, as with Carto [10]. Field
scaling and image fusion attempt to overcome this non-
linearity. Previous work by our group has confirmed that
good anatomical accuracy can be obtained by NavX fusion
when field scaling is performed and an adequate
number of fiducial points selected. The presented data
showing a navigational accuracy in clinical use of NavX
Fusion of 3.4±0.9 mm is in extremely close agreement
with the accuracy of 3.4±1.6 mm observed by Brooks
and colleagues [11] in a validation study.
Our results imply that image integration with NavX
fusion is slower than Cartomerge. More ablation
Table 4 Lesion to CT shell
distance Cartomerge NavX fusion p
No. of patients analysed 21 21
No. of lesions analysed 3,174 2,712 0.53
Mean L-CT distance (mm) 2.0±0.5 3.4±0.9 0.001
Mean patient maximum L-CT distance (mm) 10.2±0.7 15.9±1.1 0.0002





Orbitor (Bard Inc.) 10.8
Optima (St Jude Medical) 10.8
Lasso (Biosense Webster) 9.6
Irrigated RF 10.0
Navistar irrigated RF 12.3
NavX pat 8.1
Ref patch Carto 6.2
RF radiofrequency
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result with NavX fusion, possibly reflecting the higher
accuracy of image registration with Cartomerge. These
data give a mechanistic insight into improvements in
outcomes associated with image integration with Carto
XP seen in registry data, improvements not replicated
with NavX fusion [15].
Contributors to the slower registration process of NavX
fusion were not formally examined in this study. NavX
fusion requires the creation of a full LA NavX geometry to
allow image registration, whilst Cartomerge allows image
registration after acquisition of as few as three points;
further surface registration points can be targeted subjec-
tively thus minimising number of acquired points. We
hypothesise that the conceptually simpler Cartomerge
image registration thus has fewer steps and is less time-
consuming. A recent retrospective analysis of Carto- vs.
NavX-guided ablation (without specifying CT integration)
also found that Carto-guided procedures were more rapid
overall than those using NavX [16]. Thus, time differences
may not be entirely attributable to differences in CT
integration technique.
Our findings are important when considering the future
of 3D mapping technology in catheter ablation. Technolog-
ical advances have recently allowed systems to integrate
positional data from both impedance and magnetic data,
aspiring to overcome limitations of both systems. Our data
suggest that image integration in new systems would best
be primarily based on magnetic location data. We believe
that the utility, stability and accuracy of image integration
in these new systems should be independently validated in
the clinical setting.
We observed no differences in complication rates
between groups. Neither symptomatic nor asymptomatic
pulmonary vein stenosis was observed in this study, a
purported benefit of 3D image integration [7].
5 Limitations of this study
Since this study, a number of updates to both the
technologies studies have been developed. The results of
this study should be extrapolated to these newer system
versions with caution, but these newer versions are likely to
be available and used in a limited number of centres for
some time, and our data will therefore remain relevant. Our
study was performed with operators experienced in both
systems; a comparison of the learning curve using either
system was not undertaken.
In comparing the two mapping systems, to obtain
optimal outcomes and to represent best practice in both
groups, image integration was used. However, the complex
geometries created by NavX system are often adequate to
perform safe catheter ablation without 3D image integra-
tion. CartoXP anatomical maps appear simple and schema-
tic in comparison. Image integration may thus hold a
greater potential benefit for the Carto system over NavX.
Indeed, when using NavX in clinical practice, many
physicians use a pre-procedure CT to identify and exclude
variant pulmonary venous anatomy; thereafter, the geome-
try is used alone during ablation. Our clinical practice has
moved away from routine image integration with NavX
fusion as a direct result of the presented data.
6 Conclusions
Cartomerge offers faster and more reliable image registration
than NavX fusion and may require less X-ray screening.
Absolute differences between systems are small and do not
translate into important differences in procedural length, cost
or clinical outcome. Both systems can be considered equiva-
lent for the first time of catheter ablation of atrial fibrillation.
Conflicts of interest M.F. and V.B. are recipients of St Jude
Research Fellowships. M.F. is the recipient of a Wellcome Trust
Research Training Fellowship. St Jude Medical had no part in the
design, implementation or reporting of this study. R.J.S. is a member
of the scientific advisory board for Biosense Webster. He is listed on
the Speakers Bureau for Endocardial Solutions and has received
payment for lectures sponsored by them. All authors have received
support for travel to international meetings from Guidant, Medtronic,
St Jude Medical, Endocardial Solutions, and Biosense Webster.
Open Access This article is distributed under the terms of the Creative
Commons Attribution Noncommercial License which permits any
noncommercial use, distribution, and reproduction in any medium,
provided the original author(s) and source are credited.
References
1. Cappato, R., Calkins, H., Chen, S., Davies, W., Iesaka, Y.,
Kalman, J., et al. (2005). Worldwide survey on the methods,
efficacy, and safety of catheter ablation for human atrial
fibrillation. Circulation, 111(9), 1100–1105.
2. Cappato, R., Calkins, H., Chen, S., Davies, W., Iesaka, Y., Kalman,
J., et al. (2010). Updated worldwide survey on the methods, efficacy,
and safety of catheter ablation for human atrial fibrillation.
Circulation. Arrhythmia and Electrophysiology, 3(1), 32–38.
3. Powell, B., & Packer, D. (2009). Does image integration improve
atrial fibrillation ablation outcomes, or are other aspects of the
ablation the key to success? Europace, 11(8), 973–974.
4. Kistler, P., Rajappan, K., Harris, S., Earley, M., Richmond, L.,
Sporton, S., et al. (2008). The impact of image integration on
catheter ablation of atrial fibrillation using electroanatomic
mapping: a prospective randomized study. European Heart
Journal, 29(24), 3029–3036.
168 J Interv Card Electrophysiol (2012) 33:161–1695. Della Bella, P., Fassini, G., Cireddu, M., Riva, S., Carbucicchio,
C., Giraldi, F., et al. (2009). Image integration-guided catheter
ablation of atrial fibrillation: a prospective randomized study.
Journal of Cardiovascular Electrophysiology, 20(3), 258–265.
6. Bertaglia, E., Bella, P., Tondo, C., Proclemer, A., Bottoni, N., De
Ponti, R., et al. (2009). Image integration increases efficacy of
paroxysmal atrial fibrillation catheter ablation: results from the
CartoMerge Italian Registry. Europace, 11(8), 1004–1010.
7. Bertaglia, E., Brandolino, G., Zoppo, F., Zerbo, F., & Pascotto, P.
(2008). Integration of three-dimensional left atrial magnetic
resonance images into a real-time electroanatomic mapping
system: validation of a registration method. Pacing and Clinical
Electrophysiology, 31(3), 273–282.
8. Earley, M., Showkathali, R., Alzetani, M., Kistler, P., Gupta, D.,
Abrams, D., et al. (2006). Radiofrequency ablation of arrhythmias
guided by non-fluoroscopic catheter location: a prospective
randomized trial. European Heart Journal, 27(10), 1223–1229.
9. Tops, L., Bax, J., Zeppenfeld, K., Jongbloed, M., Lamb, H., van
der Wall, E., et al. (2005). Fusion of multislice computed
tomography imaging with three-dimensional electroanatomic
mapping to guide radiofrequency catheter ablation procedures.
Heart Rhythm, 2(10), 1076–1081.
10. Richmond, L., Rajappan, K., Voth, E., Rangavajhala, V., Earley,
M., Thomas, G., et al. (2008). Validation of computed tomogra-
phy image integration into the EnSite NavX mapping system to
perform catheter ablation of atrial fibrillation. Journal of
Cardiovascular Electrophysiology, 19(8), 821–827.
11. Brooks, A., Wilson, L., Kuklik, P., Stiles, M., John, B.,
Shashidhar, et al. (2008). Image integration using NavX Fusion:
initial experience and validation. Heart Rhythm, 5(4), 526–535.
12. Dong, J., Dalal, D., Scherr, D., Cheema, A., Nazarian, S.,
Bilchick, K., et al. (2007). Impact of heart rhythm status on
registration accuracy of the left atrium for catheter ablation of
atrial fibrillation. Journal of Cardiovascular Electrophysiology, 18
(12), 1269–1276.
13. Moher, D. S. K., & Altman, D. G. (2001). The CONSORT
statement: revised recommendations for improving the quality of
reports of parallel-group randomised trials. Lancet, 357(9263),
1191–1194.
14. Dong, J., Calkins, H., Solomon, S., Lai, S., Dalal, D., Lardo, A.,
et al. (2006). Integrated electroanatomic mapping with three-
dimensional computed tomographic images for real-time guided
ablations. Circulation, 113(2), 186–194.
15. Hunter, R., Ginks, M., Ang, R., Diab, I., Goromonzi, F., Page, S.,
et al. (2010). Impact of variant pulmonary vein anatomy and
image integration on long-term outcome after catheter ablation for
atrial fibrillation. Europace, 12(12), 1691–1697.
16. Khaykin, Y., Oosthuizen, R., Zarnett, L., Wulffhart, Z., Whaley,
B., Hill, C., et al. (2011). CARTO-guided vs. NavX-guided
pulmonary vein antrum isolation and pulmonary vein antrum
isolation performed without 3-D mapping: effect of the 3-D
mapping system on procedure duration and fluoroscopy time.
Journal of Interventional Cardiac Electrophysiology, 30(3),
233–240.
J Interv Card Electrophysiol (2012) 33:161–169 169